HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuyuki Arai Selected Research

Etoposide (VP 16)

12/2022Adult patients with Ph+ ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI.
1/2022Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
1/2018Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuyuki Arai Research Topics

Disease

19Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 03/2015
15Neoplasms (Cancer)
11/2023 - 10/2006
14Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 01/2018
12Graft vs Host Disease (Graft-Versus-Host Disease)
06/2023 - 07/2012
8Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 01/2021
8Prostatic Neoplasms (Prostate Cancer)
02/2015 - 11/2002
7Renal Cell Carcinoma (Grawitz Tumor)
12/2012 - 06/2007
6Philadelphia Chromosome
11/2023 - 01/2020
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 12/2019
6Residual Neoplasm
01/2022 - 10/2006
5Infections
12/2023 - 05/2015
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2023 - 07/2015
4Lymphoma (Lymphomas)
06/2023 - 06/2007
4Leukemia
12/2020 - 06/2007
4Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2019 - 07/2017
4Lymphatic Metastasis
07/2013 - 10/2006
3Cytokine Release Syndrome
01/2024 - 01/2022
3Neutropenia
01/2024 - 05/2015
3Inflammation (Inflammations)
11/2023 - 06/2007
3Virus Diseases (Viral Diseases)
09/2023 - 12/2020
3Fever (Fevers)
05/2023 - 05/2020
3Thrombotic Microangiopathies
02/2023 - 12/2013
2Mycoses (Diseases, Fungus)
04/2024 - 12/2019
2Hematologic Diseases (Blood Diseases)
04/2024 - 01/2021
2Body Weight (Weight, Body)
04/2024 - 11/2023
2Anemia
01/2024 - 01/2021
2Thrombocytopenia (Thrombopenia)
01/2024 - 12/2023
2Crohn Disease (Crohn's Disease)
11/2023 - 01/2021
2Colitis
11/2023 - 12/2022
2Acute Kidney Injury (Acute Renal Failure)
10/2023 - 12/2017
2Pathologic Complete Response
06/2023 - 01/2023
2Sepsis (Septicemia)
01/2023 - 08/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 05/2015
2Hemorrhagic Cystitis
03/2021 - 07/2012
2Autoimmune Pancreatitis
05/2020 - 01/2017
2Thrombosis (Thrombus)
01/2019 - 07/2013
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2013 - 10/2006
2Neoplasm Metastasis (Metastasis)
06/2007 - 11/2002
1Mucositis
04/2024
1Invasive Fungal Infections
04/2024
1Diarrhea
04/2024
1Peripheral Nerve Injuries
01/2024
1Ulcerative Colitis
11/2023
1Hypocalcemia
11/2023
1Hypercalcemia (Milk Alkali Syndrome)
11/2023
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2023

Drug/Important Bio-Agent (IBA)

9Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2024 - 07/2015
6Chimeric Antigen ReceptorsIBA
01/2024 - 01/2022
4Busulfan (Busulfex)FDA Link
10/2023 - 02/2020
4Rituximab (Mabthera)FDA Link
06/2023 - 05/2015
4Prednisolone (Predate)FDA LinkGeneric
06/2023 - 07/2012
4tisagenlecleucelIBA
01/2023 - 01/2021
4CytokinesIBA
01/2023 - 02/2008
4Prostate-Specific Antigen (Semenogelase)IBA
04/2012 - 11/2002
3LigandsIBA
11/2023 - 06/2005
3Tacrolimus (Prograf)FDA LinkGeneric
06/2023 - 01/2013
3fludarabineIBA
01/2023 - 02/2020
3Etoposide (VP 16)FDA LinkGeneric
12/2022 - 01/2018
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 02/2008
3Sorafenib (BAY 43-9006)FDA Link
12/2012 - 07/2011
2Tyrosine Kinase InhibitorsIBA
11/2023 - 01/2020
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2023 - 01/2021
2NucleotidesIBA
11/2023 - 01/2021
2Interleukin-6 (Interleukin 6)IBA
11/2023 - 01/2022
2Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2023 - 02/2023
2GlucocorticoidsIBA
09/2023 - 08/2007
2Calcineurin InhibitorsIBA
02/2023 - 01/2023
2Methotrexate (Mexate)FDA LinkGeneric
01/2023 - 10/2006
2Biomarkers (Surrogate Marker)IBA
01/2023 - 08/2015
2Melphalan (Alkeran)FDA LinkGeneric
11/2022 - 02/2020
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 12/2020
2Interleukin-33IBA
05/2020 - 01/2017
2Inosine Triphosphate (ITP)IBA
01/2019 - 07/2017
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 07/2017
2Cytarabine (Cytosar-U)FDA LinkGeneric
09/2015 - 07/2015
2InterferonsIBA
04/2013 - 02/2008
2SodiumIBA
01/2013 - 12/2012
2Sunitinib (Sutent)FDA Link
12/2012 - 12/2012
1posaconazoleFDA Link
04/2024
1TabletsIBA
04/2024
1Blood Proteins (Serum Proteins)IBA
04/2024
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2024
1Phosphorus (Red Phosphorus)IBA
01/2024
1Acetylmuramyl-Alanyl-IsoglutamineIBA
11/2023
1CalciumIBA
11/2023
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
11/2023
1Dextrans (Dextran)FDA Link
11/2023

Therapy/Procedure

26Therapeutics
01/2024 - 11/2002
24Hematopoietic Stem Cell Transplantation
12/2023 - 12/2013
23Transplantation
01/2024 - 01/2013
14Cell Transplantation
11/2023 - 08/2015
12Stem Cell Transplantation
10/2023 - 07/2012
11Drug Therapy (Chemotherapy)
11/2023 - 11/2002
5Blood Component Removal (Apheresis)
12/2023 - 01/2021
5Prostatectomy (Retropubic Prostatectomy)
04/2012 - 12/2009
4Radiotherapy
10/2023 - 10/2006
2Homologous Transplantation
10/2023 - 11/2019
2Donor Selection
12/2020 - 01/2016
2Nephrectomy
09/2012 - 10/2009
1Haploidentical Transplantation
02/2024